MedPath
HSA Approval

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

SIN17077P

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN 20 MCG/80 MCL

September 10, 2024

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantTEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

INJECTION, SOLUTION

SUBCUTANEOUS

Medical Information

H05AA02

Manufacturer Information

TEVA PHARMACEUTICAL INVESTMENTS SINGAPORE PTE. LTD.

PLIVA Croatia Ltd

Active Ingredients

Teriparatide

20 mcg/80 mcL

Teriparatide

Documents

Package Inserts

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN_PI.pdf

Approved: September 10, 2024

Download

Patient Information Leaflets

TERIPARATIDE-TEVA SOLUTION FOR INJECTION IN PRE-FILLED PEN_PIL.pdf

Approved: September 10, 2024

Download

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.